The ACS-GSLC association held its Ordinary Assembly on March 19th in Rome where the Board was elected for the three-year period 2015-2018 (see also section Association). As President of ACS-GSLC, Prof. Lubas was re-confirmed, assisted by Dr. Maroli as Vice-President and Dr. Founded as Secretary.
In addition, the ACS-GSLC Economic Support Collaboration Agreement was renewed with Hill's Pet Nutrition for the two-year period 2015-2016.
The CLWG Scientific Meeting in 2015 was held on July 3rd in Milan. In this meeting, the CLWG has devoted much of the meeting to some scientific study projects that actively involve some members of the group, particularly:
- Dermatitis of the nasal planum of the dog: histopathological and immune-pathological diagnostic criteria to differentiate erythematosus discoid lupus from leishmaniasis-induced skin lesions, coordinated by Dr. Fondati.
- Evaluation of clinical and laboratory remission times in dogs with proteinuria associated with leishmaniasis under different therapeutic-management protocols, coordinated by Dr. Zatelli and with the collaboration of Prof. Paltrinieri and Dr. Gradoni, Roura and Zini.
- Prevention of transmission of leishmania infectious amastigotes from blood donor dogs and arrangements to ensure proper management of blood donor dogs against Leishmaniasis, coordinated by Prof. Lubas. During this trial, medium-low IFAT titres were detected in blood donor dogs vaccinated with Canileish®. The results of these investigations were presented as an abstract at the International Congress of the European Society of Veterinary Clinical Pathology held in Milan October 1st-4th, 2014. See also download section of this website, article no. 46.
All members of the CLWG discussed the results of these above reported studies before their final publication in scientific journals, except for presenting the previews of the results in congresses.
During the meeting an important paper about leishmaniasis was thoroughly reviewed (EFSA AHAW Panel (EFSA Panel on Animal Health and Welfare, 2015. Scientific Opinion on canine leishmaniosis. EFSA Journal 2015;13(4):4075,76 pp.doi:10.2903/j.efsa.2015.4075). See also download section of this website, article no. 50.
Finally, some areas of study that will be carried out by some members of the group have been identified:
- Comparative analysis of the characteristics of all topical compounds for the prevention of leishmaniasis in the Italy (project followed by Fondati, Maroli and Gradoni).
- Developing a questionnaire for the practitioners about the prevention of leishmaniasis in the dog (project by Fondati, Maroli and Gradoni).
- Development of guidelines to establish investigations to correctly identify subjects to be vaccinated with CaniLeish ® (project by Roura, Gradoni and Lubas).
- Development of guidelines for the use of allopurinol in prolonged treatments with adverse effects assessment (project by Zini and Roura)